Dr. Ulf Grawunder
InvestorEntrepreneur in Residence at BioMedPartners
About
An experienced biotech entrepreneur and co-founder/CEO of T-CURX who has founded and exited multiple biotechnology companies including 4-Antibody AG (acquired by Agenus 2012) and NBE-Therapeutics (acquired by Boehringer Ingelheim 2021). He raised over CHF 100 million in venture funding and sits on boards of public and private biotech firms.
Colleagues at BioMedPartners
Aristotelis Nastos
Managing Partner at BioMedPartners
Claudia Ulbrich
Venture Partner at BioMedPartners
David Urech
Venture Partner at BioMedPartners
Dr. Aristotelis Nastos
Managing Partner at BioMedPartners
Dr. Claudia Ulbrich
Venture Partner at BioMedPartners
Dr. David Urech
Venture Partner at BioMedPartners
Dr. Marianna Feretzaki
Senior Associate at BioMedPartners
Dr. Markus Hosang
Managing Partner at BioMedPartners
Frequently asked questions
- Who is Dr. Ulf Grawunder?
- An experienced biotech entrepreneur and co-founder/CEO of T-CURX who has founded and exited multiple biotechnology companies including 4-Antibody AG (acquired by Agenus 2012) and NBE-Therapeutics (acquired by Boehringer Ingelheim 2021). He raised over CHF 100 million in venture funding and sits on boards of public and private biotech firms.
- Where does Dr. Ulf Grawunder work?
- Dr. Ulf Grawunder is Entrepreneur in Residence at BioMedPartners.